← All stocks

Idexx Laboratories

IDXX Net selling
CIK 0000874716 #249 in the set updated 17 Sep 2026
Bought (120 mo)
$1.51M
out of their own pocket, the only kind of buying there is
Sold (120 mo)
$733.22M
$0.00 on a plan · $576.61M straight out of an exercise
Sold at will
$156.61M
179 of 636 sales
Net
−$731.71M
−$155.10M against sales at will

By person

29 insiders · 718 transactions
38.7×

Jonathan J. Mazelsky holds 38.7 times base salary in stock. $44.59M of shares against $1.15M in salary for 2025.

Salary from the company's own proxy. The shares are what Jonathan J. Mazelsky last reported holding, valued at $532.08, the price Common Stock was last bought or sold at on the open market here, on 4 Sep 2026.

Insider
Role
Bought
Sold
Net
Holding
Of company
Worth
Change
AYERS JONATHAN W
Director
$311.03M (245) scheduled
−$311.03M
158,256
0.2009%
$84.21M
−70.1%
MCKEON BRIAN P
EVP, CFO and Treasurer
$100.51M (66) scheduled
−$100.51M
49,600
0.0630%
$26.39M
+44.8%
MAZELSKY JONATHAN JAY
President and CEO
$79.60M (79) scheduled
−$79.60M
83,803
0.1064%
$44.59M
+520.6%
TWIGGE GIOVANI
Senior Vice President
$43.99M (29) scheduled
−$43.99M
20,329
0.0258%
$10.82M
+10.5%
POLEWACZYK JAMES F
Executive Vice President
$35.68M (25) scheduled
−$35.68M
10,711
0.0136%
$5.70M
−28.7%
Lane Michael
Executive Vice President
$26.81M (33) scheduled
−$26.81M
8,024
0.0102%
$4.27M
+122.1%
SZOSTAK M ANNE
Director
$20.42M (32) scheduled
−$20.42M
778
0.0010%
$413.96K
−94.6%
Hunt Nimrata
Executive Vice President
$17.23M (14) scheduled
−$17.23M
18,141
0.0230%
$9.65M
+74.1%
FENNELL GEORGE
Executive Vice President
$16.66M (14) scheduled
−$16.66M
10,433
0.0132%
$5.55M
+104.6%
Turner Kathy V
Senior Vice President
$16.12M (24) scheduled
−$16.12M
7,380
0.0094%
$3.93M
+135.3%
HENDERSON REBECCA M
Director
$13.87M (14) scheduled
−$13.87M
14,696
0.0187%
$7.82M
−31.5%
JUNIUS DANIEL M
Director
$11.37M (11) scheduled
−$11.37M
3,561
0.0045%
$1.89M
Vandebroek Sophie V.
Director
$10.49M (13) scheduled
−$10.49M
9,078
0.0115%
$4.83M
+51.3%
Studer Jacqueline
CVP, Gen. Counsel & Secretary
$8.64M (16) scheduled
−$8.64M
4,389
0.0056%
$2.34M
+77.0%
Claflin Bruce L.
Director
$280.06K (2)
$6.63M (5) scheduled
−$6.35M
1,721
0.0022%
$915.71K
END WILLIAM T
Director
$4.78M (5)
−$4.78M
31,786
0.0403%
$16.91M
−40.8%
Erickson Michael G
Executive Vice President
$3.63M (8) scheduled
−$3.63M
15,092
0.0192%
$8.03M
+59.4%
Underberg Sharon E.
EVP, GC & Corporate Secretary
$3.55M (1) scheduled
−$3.55M
7,138
0.0091%
$3.80M
+2,039%
CRAIG THOMAS
Director
$1.02M (1) scheduled
−$1.02M
24,471
0.0311%
$13.02M
+7.8%
Kingsley Lawrence D
Director
$1.23M (5)
$1.17M (1) scheduled
+$57.64K
9,568
0.0121%
$5.09M
Emerson Andrew
EVP, CFO and Treasurer
4,421
0.0056%
$2.35M
+79.6%
Schreck Michael
Executive Vice President
3,089
0.0039%
$1.64M
+397.6%
Johnson Michael Perkins
Executive Vice President
2,795
0.0035%
$1.49M
+1,607%
ESSIG STUART
Director
2,236
0.0028%
$1.19M
Smith Martin Alexander
Executive Vice President
2,157
0.0027%
$1.15M
+1,702%
COLLINS Asha
Director
779
0.0010%
$414.49K
HOOLEY JOSEPH L
Director
325
0.0004%
$172.93K
Britt Irene Chang
Director
208
0.0003%
$110.67K
Peacock Karen
Director
102
0.0001%
$54.27K
+10,100%

Nothing of that kind in this period.

What was left out

Form 4 filings counted 563
Amendments (4/A) skipped 7
Filings about a different issuer 0
Unreadable filings 0
Joint filings 0
Sales on a Rule 10b5-1 plan 0
Sales straight out of an exercise 457
Sales at will 179
Transactions with no price 0
Shares from compensation/vesting 4,972,182
Sales filed before the plan box existed 165
History held since 2 Sep 2016